3-(1,3,5-Trimethyl-1H-pyrazol-4-yl)-propionic acid, 95.0%, 250mg

5,5-dimethyl-2-(piperazin-1-yl)-4,5-dihydrothiazole dihydrochloride, 95.0%, 1g

4-tert-Butyl L-Aspartate>98.0%(T)1g

Methyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(trifluoromethyl)benzoate, 95.0%, 5g

METHYL 3-METHYL-4-NITROISOXAZOLE-5-CARBOXYLATE, 95.0%, 2g

(3-((DIMETHYLAMINO)METHYL)-5-FLUOROPHENYL)METHANOL, 95.0%, 250mg

4-(Dimethylamino)benzhydrazide, 98.0%, 10g

1-(2-Amino-6,7-dihydro-4H-thiazolo[5,4-c]pyridin-5-yl)-ethanone, 95.0%, 1g

Pieza de transición NS-KS Conector esmerilado a conector esférico, 35, 1 pieza

(2R,3S)-2-ETHYL-3-METHYLPENTANAMIDE, 95.0%, 250mg

(R)-Benzyl-2-[4-(trifluoromethyl)phenyl]-6,7-dihydro-5H-pyrrolo[2,1-c][1,2,4]triazolium Tetrafluoroborate>97.0%(N)1g

3-(Pyridin-3-yl)benzaldehyde, 95.0%, 5g

1-(2,2-Diethoxyethyl)piperidine, 95.0%, 1g